Please assess the completion status of the following clinical trial:

Trial Title: A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Life expectancy of at least 3 months~* Histological or cytological documentation of advanced solid tumors~* ECOG Performance Status of ≤ 1 (ECOG: Eastern Cooperative Oncology Group)~* Adequate bone marrow, liver and renal function~* Women of childbearing potential and men must agree to use adequate contraception

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- TAS-114/S-1 (Type: EXPERIMENTAL): TAS-114 plus S-1

Based on this trial design, predict the completion outcome and termination type (if applicable).